Sewon Cellontech rises 5.23% amid umbilical cord blood theme uptrend
On the 16th, the cord blood theme rose 3.62% compared to the previous day, showing strength, while Sewon Cellontech, gaining attention as a related stock, surged 5.23% compared to the previous day. Sewon Cellontech is known as a company engaged in the manufacturing and sales of chemical plants, bio, and hydraulic equipment.
[Graph] Major stock price changes in the cord blood theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Sewon Cellontech's quant financial score was 18.82 points, ranking 5th in the quant financial ranking within the cord blood-related theme. This can be interpreted as Sewon Cellontech having relatively low investment attractiveness from a financial perspective. On the other hand, Green Cross ranked 1st in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.
[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.
Hot Picks Today
No Bacteria Detected in Arisu After 24 Hours of Repeated Drinking from a Tumbler
- "We Can't Just Let Them Be Damaged Inside"... Samsung Electronics Removes 360,000 Wafers in Preparation for Strike
- "Up to 100 Trillion Won in Losses Feared, It's Not About Second Place but Catastrophe"... Industry Minister: 'Emergency Mediation Unavoidable If Samsung Strike Occurs'
- Wife in $6.7 Million Debt Took Out $3 Million in Husband's Life Insurance, Poisoned Him... US Court: "She Can Never Be Released"
- "He's Handsome, It's Such a Pity?"... Lawyer Responds to Bizarre 'Appearance Evaluation' of High School Girl Murder Suspect
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.